New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For SPPI From The Last 14 Days
Check below for free stories on SPPI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 21, 2014
10:02 EDTSPPISpectrum weakness attributed to FDA comment on Fusilev generics
The move lower in shares of Spectrum is being attributed to circulation of a Department of Health and Human Services document which states the FDA will be able to approve abbreviated new drug applications for levoleucovorin calcium, the trade name of Spectrum's Fusilev. Shares of Spectrum are down 4%, or 33c, to $7.42. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use